Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 28, Issue 6, Pages 836-844
Publisher
Springer Nature
Online
2015-02-27
DOI
10.1038/modpathol.2015.43
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing
- (2014) Caroline C. Billingsley et al. CANCER
- POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
- (2014) Bo Meng et al. GYNECOLOGIC ONCOLOGY
- High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma
- (2014) Ellen Stelloo et al. GYNECOLOGIC ONCOLOGY
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- Classification of endometrial carcinoma: more than two types
- (2014) Rajmohan Murali et al. LANCET ONCOLOGY
- Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
- (2014) Vivian M. Spaans et al. PLoS One
- The target therapy of ovarian clear cell carcinoma
- (2014) Ying Jin et al. OncoTargets and Therapy
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
- (2013) J G van Oosterwijk et al. BRITISH JOURNAL OF CANCER
- The Emerging Genomic Landscape of Endometrial Cancer
- (2013) M. Le Gallo et al. CLINICAL CHEMISTRY
- DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer
- (2013) David N. Church et al. HUMAN MOLECULAR GENETICS
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
- (2013) Tjalling Bosse et al. MODERN PATHOLOGY
- The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
- (2013) Oluwole Fadare et al. MODERN PATHOLOGY
- Reproducibility of histological cell type in high-grade endometrial carcinoma
- (2013) Guangming Han et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
- (2012) B. M. Slomovitz et al. CLINICAL CANCER RESEARCH
- Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis
- (2012) Ronald van Eijk et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation
- (2012) Remi A. Nout et al. GYNECOLOGIC ONCOLOGY
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
- (2011) W Glenn McCluggage et al. HISTOPATHOLOGY
- Pathologic Scoring of PTEN Immunohistochemistry in Endometrial Carcinoma is Highly Reproducible
- (2011) Karuna Garg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Emerging therapeutic targets in endometrial cancer
- (2011) Konstantin J. Dedes et al. Nature Reviews Clinical Oncology
- Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
- (2010) Eddy HJ van Roon et al. BMC CANCER
- Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)
- (2010) Helen J. Mackay et al. EUROPEAN JOURNAL OF CANCER
- FGFR2 as a molecular target in endometrial cancer
- (2009) Sara A Byron et al. Future Oncology
- Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma
- (2009) Haitham Arabi et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now